DeepMind’s Latest AlphaFold AI Model Rev...

In this episode, Jaeden discusses the recent release of the 11 Labs Music API, the first music API for developers trained on licensed data and cleared for broad commercial use. He explores its features, potential applications, and the implications for artists and the music indust ... Show More

In this episode of the AI Chat podcast, hosts Jaeden, Twain Martin, and Rogerio Andrade delve into the transformative power of AI in gaming and beyond. They explore Twain's extensive background in game development, including his work on iconic titles like World of Warcraft, and R ... Show More

In this episode, Jaeden discusses Perplexity's bold $34.5 billion unsolicited offer to acquire Google Chrome amidst ongoing antitrust issues facing Google. The conversation explores the implications of this offer, the competitive landscape of web browsers, and the potential for s ... Show More

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ... Show More

Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ... Show More

Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is i ... Show More

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More

In this episode, we explore OpenAI's new SearchGPT model and its potential to challenge Google and Perplexity in the search engine landscape. We discuss the features and capabilities that set SearchGPT apart as OpenAI's latest innovation in AI-powered search. Get on the AI Box Wa ... Show More

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ... Show More

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More

Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research ... Show More

Former OpenAI researcher Leopold Aschenbrenner has released a series of essays talking about how he sees AI playing out and what we should all do about it. Pete digs into his extremely impressive background and his arguments around why we’re about to get AGI. Transcripts: ⁠https: ... Show More